Target intelligence / Profile preview

Bladder urothelial mucosal surface (None)

Target
None
Molecular classification
Other
01

Overview

The bladder urothelial mucosal surface is a complex biological barrier consisting of the transitional epithelium (urothelium) and an overlying layer of sulfated glycosaminoglycans (GAGs). Its primary biological function is to serve as an impermeable shield that prevents the diffusion of water, urea, and toxic solutes from the urine into the underlying detrusor muscle and neural plexuses (StatPearls, 2023). This barrier is maintained by specialized proteins called uroplakins, which form the asymmetric unit membrane, and tight junction proteins like claudins (PubMed, 2019). In pathological states such as interstitial cystitis/bladder pain syndrome (IC/BPS), the GAG layer is often deficient or damaged, leading to increased mucosal permeability and the activation of subepithelial sensory nerves by urinary potassium (NIH, 2022). Pharmacological intervention typically involves intravesical barrier replenishment therapy using exogenous GAG analogs like pentosan polysulfate or hyaluronic acid to restore the protective coating (Journal of Urology, 2021). Furthermore, the urothelium acts as a transducer of mechanical and chemical stimuli, releasing signaling molecules like ATP and nitric oxide to modulate bladder sensation and voiding function (Nature Reviews Urology, 2019).

Other names
Urothelial barrierGlycosaminoglycan layerBladder mucosaTransitional epitheliumGAG layer
02

Mechanism of action

Restoration of the glycosaminoglycan (GAG) layer and enhancement of the urothelial barrier to prevent the penetration of urinary irritants into the bladder wall.

03

Biological functions

Barrier functionSignal transductionImmune responseOsmoregulation
04

Disease associations

Interstitial cystitisBladder cancerUrinary tract infectionOveractive bladder
05

Safety considerations

Urinary tract infectionSystemic absorption of intravesical agentsChemical cystitisBladder irritation
06

Interacting drugs

Pentosan polysulfate sodium

4 more in the full profile.

07

Biomarkers

Uroplakin IIIAntiproliferative factorHeparin-binding epidermal growth factor-like growth factor

Beyond the preview

Go deeper on Bladder urothelial mucosal surface (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bladder urothelial mucosal surface (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call